References
- Bornstein J, Goldstein AT, Stockdale CK, Bergeron S, Pukall C, Zolnoun D, et al. 2016. 2015 ISSVD, ISSWSH, and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia. Journal of Lower Genital Tract Disease 20:126–130.
- Cano A, Estévez J, Usandizaga R, Gallo JL, Guinot M, Delgado JL, et al. 2012. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study. Menopause 19:1130–1139.
- Cea García J, Márquez Maraver F, Rubio Rodríguez MC. 2021. Cross-sectional study on the impact of age, menopause and quality of life on female sexual function. Journal of Obstetrics and Gynaecology 1–8. Epub ahead of print.doi: 10.1080/01443615.2021.1945017
- Delgado JL, Estevez J, Radicioni M, Loprete L, Moscoso Del Prado J, Nieto Magro C. 2016. Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women. Climacteric : The Journal of the International Menopause Society 19:172–180.
- Ghizzani A, Luisi S, Cartocci A, Cevenini G. 2020. Genitopelvic pain: retrospective evaluation of a multimodal treatment efficacy. Minerva ginecologica 72:123–131.
- Lee NMW, Jakes AD, Lloyd J, Frodsham LCG. 2018. Dyspareunia. BMJ (Clinical Research ed.) 361:k2341.
- Nappi RE, Cucinella L. 2021. Sexuality, pelvic floor/vaginal health and contraception at menopause. Best Practice & Research Clinical Obstetrics & Gynaecology 81:85–97.
- Phillips NA, Bachmann GA. 2021. The genitourinary syndrome of menopause. Menopause (New York, N.Y.) 28:579–588.